Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
571.00
-2.91 (-0.51%)
At close: Aug 19, 2025, 3:59 PM
571.61
0.11%
After-hours: Aug 19, 2025, 04:20 PM EDT
Regeneron Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.21B | 14.09B | 14.2B | 13.85B | 13.49B | 13.1B | 13.12B | 13.1B | 12.67B | 12.37B | 12.17B | 13.71B | 14.23B | 16.51B | 16.07B | 13.54B | 12.38B | 9.2B |
Cost of Revenue | 2.56B | 2.5B | 2.45B | 2.39B | 2.32B | 2.23B | 2.24B | 2.11B | 1.98B | 1.85B | 1.77B | 2.32B | 2.43B | 2.83B | 2.72B | 2.08B | 1.89B | 1.46B |
Gross Profit | 11.65B | 11.59B | 11.75B | 11.46B | 11.17B | 10.87B | 10.88B | 10.98B | 10.69B | 10.52B | 10.4B | 11.39B | 11.79B | 13.68B | 13.35B | 11.46B | 10.5B | 7.74B |
Operating Income | 3.96B | 3.96B | 4.11B | 4.14B | 4.11B | 4.04B | 4.28B | 4.55B | 4.56B | 4.85B | 5.13B | 6.46B | 7.08B | 9.12B | 8.95B | 7.47B | 6.68B | 3.99B |
Interest Income | 718.8M | 723.4M | 711.4M | 677M | 623.3M | 562.2M | 400.7M | 252M | 118.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 4.87B | 4.98B | 4.78B | 4.97B | 4.59B | 4.04B | 4.2B | 4.38B | 4.78B | 4.66B | 4.86B | 6.04B | 6.34B | 9.13B | 9.33B | 8.05B | 7.23B | 4.39B |
Net Income | 4.46B | 4.5B | 4.41B | 4.65B | 4.32B | 3.86B | 3.95B | 3.99B | 4.3B | 4.18B | 4.34B | 5.37B | 5.69B | 7.93B | 8.08B | 7B | 6.21B | 4B |
Selling & General & Admin | 2.77B | 2.89B | 2.95B | 2.87B | 2.79B | 2.69B | 2.6B | 2.55B | 2.44B | 2.26B | 2.11B | 2.02B | 1.93B | 1.87B | 1.82B | 1.57B | 1.45B | 1.38B |
Research & Development | 4.91B | 4.7B | 4.64B | 4.41B | 4.23B | 4.14B | 4B | 3.9B | 3.74B | 3.48B | 3.25B | 3.02B | 2.79B | 2.72B | 2.62B | 2.59B | 2.63B | 2.65B |
Other Expenses | 23.5M | 38.1M | 53.4M | 37.4M | 28.9M | 13.7M | -2.1M | -8.2M | -53.4M | -70.2M | -89.9M | -99.1M | -11.4M | -25.3M | -45.6M | -175M | -261.6M | -280.5M |
Operating Expenses | 7.7B | 7.63B | 7.63B | 7.32B | 7.06B | 6.84B | 6.6B | 6.44B | 6.13B | 5.68B | 5.27B | 4.94B | 4.71B | 4.56B | 4.4B | 3.99B | 3.82B | 3.75B |
Interest Expense | 36.6M | 47.8M | 55.2M | 63M | 67M | 71.1M | 73M | 72.1M | 69.6M | 63.8M | 59.4M | 56.1M | 55M | 56.3M | 57.3M | 58M | 70.1M | 65.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.26B | 10.13B | 10.09B | 9.71B | 9.38B | 9.06B | 8.84B | 8.55B | 8.11B | 7.52B | 7.04B | 7.25B | 7.15B | 7.39B | 7.12B | 6.07B | 5.7B | 5.21B |
Income Tax Expense | 416.2M | 484.9M | 367.3M | 314.9M | 265.5M | 184.2M | 245.7M | 385.3M | 476.4M | 473M | 520.4M | 667.2M | 657.5M | 1.2B | 1.25B | 1.05B | 1.02B | 391M |
Shares Outstanding (Basic) | 105.1M | 106.7M | 107.9M | 108.1M | 108.1M | 107.8M | 106.6M | 106.3M | 107M | 107.1M | 107M | 112.8M | 114M | 113.07M | 106.2M | 106.2M | 105M | 110.5M |
Shares Outstanding (Diluted) | 108.6M | 111.2M | 113.8M | 116.2M | 115.4M | 115.1M | 113.8M | 113.4M | 113.9M | 114M | 114M | 112.8M | 114M | 113.1M | 113.2M | 113.9M | 110.8M | 110.53M |
EPS (Basic) | 41.75 | 41.76 | 40.88 | 43.23 | 40.31 | 36.11 | 37.05 | 37.36 | 39.54 | 37.96 | 38.93 | 48.73 | 52.44 | 74.48 | 76.45 | 66.37 | 58.98 | 37.65 |
EPS (Diluted) | 39.68 | 39.28 | 38.28 | 40.41 | 37.76 | 33.85 | 34.75 | 35.06 | 37.83 | 36.80 | 38.24 | 47.43 | 50.10 | 70.60 | 72.08 | 62.63 | 55.69 | 35.33 |
EBITDA | 5.42B | 5.53B | 5.32B | 5.5B | 5.11B | 4.55B | 4.69B | 4.86B | 5.24B | 5.09B | 5.26B | 6.41B | 6.7B | 9.48B | 9.67B | 8.38B | 7.56B | 4.71B |
EBIT | 4.91B | 5.03B | 4.84B | 5.03B | 4.65B | 4.11B | 4.27B | 4.45B | 4.84B | 4.72B | 4.92B | 6.09B | 6.4B | 9.19B | 9.38B | 8.11B | 7.3B | 4.46B |
Depreciation & Amortization | 510.1M | 495.7M | 482.9M | 469.5M | 453.2M | 435.6M | 421M | 408.1M | 395.3M | 366.6M | 341.4M | 315.8M | 296.4M | 293.1M | 286.2M | 273.4M | 259.5M | 247.2M |